Cargando…

The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer

BACKGROUND: The DNA mismatch repair (MMR) pathway is an important post-replicative repair process. It is involved in the maintenance of genomic stability and MMR genes have therefore been named the proofreaders of replicating DNA. These genes repair the replicative errors of DNA and are thus imperat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chintamani, Jha, Binita P, Bhandari, Vimal, Bansal, Anju, Saxena, Sunita, Bhatnagar, Dinesh
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802872/ https://www.ncbi.nlm.nih.gov/pubmed/17394628 http://dx.doi.org/10.1186/1477-7800-4-5

Ejemplares similares

Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer? -A prospective clinical study
por: Chintamani, et al.
Publicado: (2004)

Isolated colostomy site recurrence in rectal cancer-two cases with review of literature
por: Chintamani, et al.
Publicado: (2007)

Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer - a prospective study
por: Chintamani, et al.
Publicado: (2011)

Is an aggressive approach justified in the management of an aggressive cancer-the squamous cell carcinoma of thyroid?
por: Chintamani, et al.
Publicado: (2007)

Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors
por: Mishra, Ashwani K., et al.
Publicado: (2012)

Qualitative and quantitative dermatoglyphic traits in patients with breast cancer: a prospective clinical study
por: Chintamani, et al.
Publicado: (2007)

Carcinoma developing in a fibroadenoma in a woman with a family history of breast cancer: a case report and review of literature
por: Chintamani, et al.
Publicado: (2009)

Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women
por: Chintamani, et al.
Publicado: (2010)

Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer-a prospective clinical study
por: Chintamani, et al.
Publicado: (2005)

Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer- a prospective randomized clinical trial[ISRCTN24484328]
por: Chintamani, et al.
Publicado: (2005)

Residual Tumor Patterns of Breast Cancer on MRI after Neo-Adjuvant Chemotherapy: Impact on Clinicopathologic Factors and Prognosis
por: Cha, Yoon Jin, et al.
Publicado: (2022)

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
por: Bansal, GJ, et al.
Publicado: (2015)

Extramedullary Hematopoiesis in Mismatch Repair Deficient Colon Cancer Patient on Adjuvant Chemotherapy
por: De Leo, Edward K, et al.
Publicado: (2021)

Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India-A cross-sectional study
por: Saxena, Sunita, et al.
Publicado: (2005)

Squamous cell carcinoma developing in the scar of Fournier's gangrene – Case report
por: Chintamani, et al.
Publicado: (2004)

Metastatic sweat gland adenocarcinoma: A clinico-pathological dilemma
por: Chintamani, et al.
Publicado: (2003)

Clinicopathologic features of endometrial cancer with mismatch repair deficiency
por: Gordhandas, Sushmita, et al.
Publicado: (2020)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

Metastasizing granular cell ameloblastoma
por: Bansal, Anju, et al.
Publicado: (2012)

Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
por: Song, Wu, et al.
Publicado: (2012)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
por: Findlay, John M., et al.
Publicado: (2016)

Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer
por: Chang, Alex Yuang-Chi, et al.
Publicado: (2016)

Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
por: Bhattacharyya, G. S., et al.
Publicado: (2018)

Neo-adjuvant chemotherapy in stage IIIC potentially resectable epithelial ovarian cancer
por: Voutsadakis, Ioannis A.
Publicado: (2016)

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
por: Constantinidou, Anastasia, et al.
Publicado: (2020)

Genetic variations in triple-negative breast cancers undergoing neo-adjuvant chemotherapy
por: Mori, Miki, et al.
Publicado: (2019)

Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapy
por: Koppiker, Chaitanyanand B., et al.
Publicado: (2023)

Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer
por: Schroyen, Gwen, et al.
Publicado: (2023)

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer compared to other subtypes of breast cancer
por: Bansal, Gaurav J, et al.
Publicado: (2016)

Kimura's disease masquerading as parotid malignancy
por: Chintamani,, et al.
Publicado: (2010)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
por: Dikken, Johan L, et al.
Publicado: (2011)

Objective physical and mental markers of self‐reported fatigue in women undergoing (neo)adjuvant chemotherapy for early‐stage breast cancer
por: Mortimer, Joanne E., et al.
Publicado: (2017)

Combination of primary tumor location and mismatch repair status guides adjuvant chemotherapy in stage II colon cancer
por: Yang, Lin, et al.
Publicado: (2017)

NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
por: Raut, Nirmal V, et al.
Publicado: (2010)

Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
por: Drooger, Jan C., et al.
Publicado: (2016)

Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
por: Rossi, Luigi, et al.
Publicado: (2012)

Neo Adjuvant Chemotherapy on Testicular Cancer after Scrotal Exploration: A Case Report
por: Novianda, Andhika H., et al.
Publicado: (2019)

NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin
por: Yeo, Winnie, et al.
Publicado: (2022)

Evaluation of Neo-Adjuvant, Concurrent and Adjuvant Chemotherapy in the Treatment of Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Akhlaghi, Fahimeh, et al.
Publicado: (2014)

Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma
por: Kaur, Gurjeet, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2l231rbnuc3ebfjv4bcqviilje